Gain Therapeutics Inc (GANX)
2.58
-0.11
(-4.09%)
USD |
NASDAQ |
May 17, 16:00
2.58
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics 1 Year Total Returns (Daily): -45.66% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 16, 2024 | -45.66% |
| May 15, 2024 | -48.43% |
| May 14, 2024 | -54.74% |
| May 13, 2024 | -53.19% |
| May 10, 2024 | -51.54% |
| May 09, 2024 | -50.78% |
| May 08, 2024 | -49.62% |
| May 07, 2024 | -47.27% |
| May 06, 2024 | -48.18% |
| May 03, 2024 | -42.64% |
| May 02, 2024 | -44.03% |
| May 01, 2024 | -43.21% |
| April 30, 2024 | -41.75% |
| April 29, 2024 | -40.36% |
| April 26, 2024 | -41.05% |
| April 25, 2024 | -37.85% |
| April 24, 2024 | -36.45% |
| April 23, 2024 | -37.57% |
| April 22, 2024 | -41.62% |
| April 19, 2024 | -36.02% |
| April 18, 2024 | -35.45% |
| April 17, 2024 | -33.75% |
| April 16, 2024 | -34.03% |
| April 15, 2024 | -35.49% |
| April 12, 2024 | -31.67% |
| Date | Value |
|---|---|
| April 11, 2024 | -25.33% |
| April 10, 2024 | -29.23% |
| April 09, 2024 | -29.44% |
| April 08, 2024 | -28.39% |
| April 05, 2024 | -23.93% |
| April 04, 2024 | -23.01% |
| April 03, 2024 | -17.90% |
| April 02, 2024 | -19.29% |
| April 01, 2024 | -20.54% |
| March 28, 2024 | -19.44% |
| March 27, 2024 | -21.47% |
| March 26, 2024 | -22.45% |
| March 25, 2024 | -25.51% |
| March 22, 2024 | -17.31% |
| March 21, 2024 | -15.31% |
| March 20, 2024 | -13.06% |
| March 19, 2024 | -8.01% |
| March 18, 2024 | -5.63% |
| March 15, 2024 | -2.94% |
| March 14, 2024 | 1.66% |
| March 13, 2024 | 9.93% |
| March 12, 2024 | 24.25% |
| March 11, 2024 | 27.25% |
| March 08, 2024 | 20.05% |
| March 07, 2024 | 20.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.64%
Minimum
May 24 2022
92.19%
Maximum
May 12 2023
-19.81%
Average
-15.53%
Median
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly and Co | 77.90% |
| Alpine Immune Sciences Inc | 658.0% |
| Outlook Therapeutics Inc | -69.20% |
| OptiNose Inc | -31.38% |
| Greenwich LifeSciences Inc | 27.09% |